Union of forces advances myeloma care

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

In this issue of Blood, Richardson et al report on a landmark treatment regimen for newly diagnosed myeloma patients that for the first time combines lenalidomide and bortezomib. This effort required a team approach comprising 2 competing pharmaceutical companies (joining forces to study this promising regimen) and multiple academic medical centers.

Original languageEnglish (US)
Pages (from-to)674-675
Number of pages2
JournalBlood
Volume116
Issue number5
DOIs
StatePublished - Aug 5 2010

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Union of forces advances myeloma care'. Together they form a unique fingerprint.

  • Cite this